Ligand Pharmaceuticals Aktie
238,00
EUR
±0,00
EUR
±0,00
%
275,52
USD
+12,25
USD
+4,65
%
Ligand Pharmaceuticals jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Ligand Pharmaceuticals Aktie Analyse
| 11.06.19 | Ligand Pharmaceuticals Equal weight | Barclays Capital | |
| 15.06.15 | Ligand Pharmaceuticals Hold | Deutsche Bank AG | |
| 05.08.09 | Ligand Pharmaceuticals neutral | Merriman Curhan Ford & Co | |
| 17.03.06 | Ligand Pharmaceuticals neutral | First Albany | |
| 17.03.06 | Ligand Pharmaceuticals Neutral | First Albany | |
| 19.01.06 | Ligand Pharmaceuticals market perform | Evern Securities | |
| 18.01.06 | Ligand Pharmaceuticals Market Perform | Friedman, Billings Ramsey & Co | |
| 16.05.05 | Ligand Pharmaceuticals Hold | Legg Mason | |
|
Werbung
|
|||
| 28.03.05 | Ligand Pharmaceuticals Neutral | Ferris Baker Watts | |
Werbung
Werbung